Co-delivery of CO/H<sub>2</sub> gases for synergistic radiosensitization and intestinal protection in peritoneal metastases therapy.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 41130124.
- Also identified by DOI 10.1016/j.biomaterials.2025.123796.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The combination of radiosensitizing carbon monoxide (CO) and radioprotective hydrogen (H<sub>2</sub>) holds significant potential in whole abdominal radiotherapy for the treatment of peritoneal metastases of colon cancer. However, the concurrent and controlled release of dual gases poses substantial challenges because of their inherently unstable and uncoordinated release profiles. Here, we develop a novel dual gas nanosystem by encapsulating unstable iron carbonyl (FeCO) and ammonium borane (AB) within a stable silica matrix, enabling the on-demand release of CO and H<sub>2</sub>. This dual-gas nanosystem prevents premature release in acidic gastric environments and enables the sustained release (>50 h) of H<sub>2</sub> in the intestinal tract, effectively providing protection against radiotherapy-induced intestinal injury. Notably, upon X-ray irradiation of the tumor site, the nanosystem rapidly releases CO to increase radiosensitivity while concurrently releasing H<sub>2</sub> to repair radiation-induced intestinal damage. This spatiotemporal control over the release of CO and H<sub>2</sub> offers a promising therapeutic strategy for efficiently treating peritoneal metastases while reducing the adverse effects associated with radiation therapy.
Medical subject headings
- Peritoneal Neoplasms
- Carbon Monoxide
- Hydrogen
- Radiation-Sensitizing Agents
- Intestines